Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267818.RAugzEv0SIC90dn7KTxnnT4PYRqiN7USHgZqVP5oe-d58130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267818.RAugzEv0SIC90dn7KTxnnT4PYRqiN7USHgZqVP5oe-d58130_assertion type Assertion NP1267818.RAugzEv0SIC90dn7KTxnnT4PYRqiN7USHgZqVP5oe-d58130_head.
- NP1267818.RAugzEv0SIC90dn7KTxnnT4PYRqiN7USHgZqVP5oe-d58130_assertion description "[The present findings suggest that Med19 facilitates tumorigenic properties of NSCLC cells and knockdown of Med19 may be a rational therapeutic tool for lung cancer cisplatin sensitization.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267818.RAugzEv0SIC90dn7KTxnnT4PYRqiN7USHgZqVP5oe-d58130_provenance.
- NP1267818.RAugzEv0SIC90dn7KTxnnT4PYRqiN7USHgZqVP5oe-d58130_assertion evidence source_evidence_literature NP1267818.RAugzEv0SIC90dn7KTxnnT4PYRqiN7USHgZqVP5oe-d58130_provenance.
- NP1267818.RAugzEv0SIC90dn7KTxnnT4PYRqiN7USHgZqVP5oe-d58130_assertion SIO_000772 25735376 NP1267818.RAugzEv0SIC90dn7KTxnnT4PYRqiN7USHgZqVP5oe-d58130_provenance.
- NP1267818.RAugzEv0SIC90dn7KTxnnT4PYRqiN7USHgZqVP5oe-d58130_assertion wasDerivedFrom befree-2016 NP1267818.RAugzEv0SIC90dn7KTxnnT4PYRqiN7USHgZqVP5oe-d58130_provenance.
- NP1267818.RAugzEv0SIC90dn7KTxnnT4PYRqiN7USHgZqVP5oe-d58130_assertion wasGeneratedBy ECO_0000203 NP1267818.RAugzEv0SIC90dn7KTxnnT4PYRqiN7USHgZqVP5oe-d58130_provenance.